SR
Salveen Richter Goldman Sachs Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
40
Avg Return
Past Year
Past Year
23%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
22.2%
Neutral
66.7%
Negative
11.1%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Industrials
Technology
Financials
Credit Services
Healthcare
Biotechnology
Drug Manufacturers - General
Medical Care Facilities
Industrials
Farm & Heavy Construction Machinery
Technology
Software - Application
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $25 |
9%
downside
| 1 | – |
–
| 20 Nov ‘25 13 days ago |
|
|
|
Neutral
Maintained
| $11 |
12%
upside
| 1 | – |
–
| 5 Nov ‘25 28 days ago |
|
|
|
Neutral
Maintained
| $38 |
49%
upside
| 2 | – |
–
| 4 Nov ‘25 29 days ago |
|
|
|
Neutral
Maintained
| $16 |
38%
downside
| 1 | – |
–
| 30 Oct ‘25 1 month ago |
|
|
|
Neutral
Upgraded
| $65 |
21%
downside
| 1 | -9.5% |
0
%
| 26 Sep ‘25 2 months ago |
|
|
|
Sell
Downgraded
| $18 |
15%
downside
| 1 | +4.4% |
0
%
| 26 Sep ‘25 2 months ago |
|
|
|
Buy
Initiated
| $26 |
34%
upside
| 1 | +106% |
0
%
| 22 Sep ‘25 2 months ago |
|
|
|
Buy
Maintained
| $566 |
20%
upside
| 1 | +2.6% |
0
%
| 16 Sep ‘25 2 months ago |
|